DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

0.6999
Delayed Data
As of Jun 22
 -0.0526 / -6.99%
Today’s Change
0.66
Today|||52-Week Range
2.84
-35.79%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Zarrabian Saiid
Interim Chief Executive Officer
Buy11/14/201755,000$0.82$45.1K-16.38%
Bacha Jeffrey A
Chief Executive Officer
Buy6/26/20176,700$3.60$24.1K-67.89%
Bell John K
Director
Buy6/26/20174,167$3.60$15.0K-67.89%
Mohr Erich
Director
Buy6/26/20174,167$3.60$15.0K-67.89%
Praill Scott
Chief Financial Officer
Buy6/26/20174,167$3.60$15.0K-67.89%
Praill Scott
Chief Financial Officer
Buy10/05/201717,500$0.85$14.9K-20.47%
Bell John K
Director
Buy11/16/201718,129$0.81$14.7K-12.62%
Cranston Lynda
Director
Buy6/26/20172,083$3.60$7.5K-67.89%
Bacha Jeffrey A
Chief Executive Officer
Buy10/06/20177,550$0.87$6.6K-20.83%
Zarrabian Saiid
Interim Chief Executive Officer
Buy11/14/20175,900$0.84$5.0K-16.38%
Page of 2